BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 8691347)

  • 21. The histopathology of Langerhans cell histiocytosis.
    Favara BE; Jaffe R
    Br J Cancer Suppl; 1994 Sep; 23():S17-23. PubMed ID: 7521200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenesis of adult pulmonary Langerhans-cell histiocytosis].
    Tazi A; Soler P; Hance AJ
    Rev Mal Respir; 1999 Apr; 16(2):151-9. PubMed ID: 10339758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Langerhans cell histiocytosis of lymph nodes: a morphological assessment of 43 biopsies.
    Favara BE; Steele A
    Pediatr Pathol Lab Med; 1997; 17(5):769-87. PubMed ID: 9267889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal tract langerhans cell histiocytosis: A clinicopathologic study of 12 patients.
    Singhi AD; Montgomery EA
    Am J Surg Pathol; 2011 Feb; 35(2):305-10. PubMed ID: 21263252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical cellular disorders.
    McClain KL; Natkunam Y; Swerdlow SH
    Hematology Am Soc Hematol Educ Program; 2004; ():283-96. PubMed ID: 15561688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sinus histiocytosis with massive lymphadenopathy and Langerhans cell histiocytosis express the cellular adhesion molecule CD31.
    Slone SP; Fleming DR; Buchino JJ
    Arch Pathol Lab Med; 2003 Mar; 127(3):341-4. PubMed ID: 12653580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutaneous Rosai-Dorfman disease with increased number of eosinophils: coincidence or histologic variant?
    Cangelosi JJ; Prieto VG; Ivan D
    Arch Pathol Lab Med; 2011 Dec; 135(12):1597-600. PubMed ID: 22129191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome.
    Geissmann F; Emile JF; Andry P; Thomas C; Fraitag S; De Prost Y; Brousse N
    J Pathol; 1997 Mar; 181(3):301-4. PubMed ID: 9155716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: towards a new therapeutic approach.
    Aouba A; Terrier B; Vasiliu V; Candon S; Brousse N; Varet B; Hermine O
    Haematologica; 2006 Dec; 91(12 Suppl):ECR52. PubMed ID: 17194658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Cutaneous Rosai-Dorfman Disease and Localized Cutaneous Langerhans Cell Histiocytosis Within a Single Subcutaneous Nodule.
    Litzner BR; Subtil A; Vidal CI
    Am J Dermatopathol; 2015 Dec; 37(12):936-9. PubMed ID: 26588339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density.
    Foss HD; Herbst H; Gottstein S; Demel G; Araujó I; Stein H
    Am J Pathol; 1996 Apr; 148(4):1229-36. PubMed ID: 8644863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in telomerase expression by the CD1a+ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease.
    da Costa CE; Egeler RM; Hoogeboom M; Szuhai K; Forsyth RG; Niesters M; de Krijger RR; Tazi A; Hogendoorn PC; Annels NE
    J Pathol; 2007 Jun; 212(2):188-97. PubMed ID: 17447723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Faisalabad histiocytosis mimics Rosai-Dorfman disease: brothers with lymphadenopathy, intrauterine fractures, short stature, and sensorineural deafness.
    Rossbach HC; Dalence C; Wynn T; Tebbi C
    Pediatr Blood Cancer; 2006 Oct; 47(5):629-32. PubMed ID: 16155931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
    Hage C; Willman CL; Favara BE; Isaacson PG
    Hum Pathol; 1993 Aug; 24(8):840-5. PubMed ID: 7690735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rosai-Dorfman disease: a case with lymphadenopathy and liver involvement.
    Maheshwari A; Seth A; Choudhury M; Aggarwal V; Patra B; Aggarwal S; Mukherjee SB; Aneja S
    J Pediatr Hematol Oncol; 2009 Mar; 31(3):200-2. PubMed ID: 19262248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.
    Lau SK; Chu PG; Weiss LM
    Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biology of Langerhans cells and Langerhans cell histiocytosis.
    Bechan GI; Egeler RM; Arceci RJ
    Int Rev Cytol; 2006; 254():1-43. PubMed ID: 17147996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sinus histiocytosis with massive lymphadenopathy--a review of seven cases.
    Agarwal A; Pathak S; Gujral S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):509-15. PubMed ID: 17183839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic cell marker.
    Pinkus GS; Lones MA; Matsumura F; Yamashiro S; Said JW; Pinkus JL
    Am J Clin Pathol; 2002 Sep; 118(3):335-43. PubMed ID: 12219775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.
    Willman CL; Busque L; Griffith BB; Favara BE; McClain KL; Duncan MH; Gilliland DG
    N Engl J Med; 1994 Jul; 331(3):154-60. PubMed ID: 8008029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.